Concepedia

Daisuke Okajima

DO

5

Publications

175

Citations

5

H-Index

2010

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (United States)

Daisuke Okajima is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and lung cancer.

Top concepts

Publications per year

2010–2024

5

Publications

5

Brain-specific angiogenesis inhibitor 2 (BAI2) may be activated by proteolytic processing

Daisuke Okajima, Gen Kudo, Hiroshi Yokota · Journal of Receptors and Signal Transduction · 2010 · 84 citations

, , +22

Antidepressant-like behavior in brain-specific angiogenesis inhibitor 2-deficient mice

Daisuke Okajima, Gen Kudo, Hiroshi Yokota · The Journal of Physiological Sciences · 2010 · 47 citations · Full text

, , +15

Preclinical efficacy studies of DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd.

Daisuke Okajima, Satoru Yasuda, Yusuke Yokouchi et al. · Journal of Clinical Oncology · 2018 · 16 citations

, , +20

First-in-human phase 1 study of DS-1062a in patients with advanced solid tumors.

Jacob Sands, Toshio Shimizu, Edward B. Garon et al. · Journal of Clinical Oncology · 2019 · 15 citations

, , +17

Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models

Funda Meric‐Bernstam, Erkan Yuca, Kurt W. Evans et al. · Clinical Cancer Research · 2024 · 13 citations · Full text

Rows per page

1–5 of 5